BioCentury | Oct 28, 2020
Deals

Out of the Arena: With $56M round, spinout Longboard to house trio of neuroscience programs

...Pharmaceuticals Inc. (NASDAQ:ARNA) took a major step in January, when the parent company formed its Arena Neuroscience Inc....
BioCentury | Feb 29, 2020
Management Tracks

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

...said EVP and CFO Kevin Lind will transition to president and CEO of its subsidiary Arena Neuroscience Inc....
Items per page:
1 - 2 of 2
BioCentury | Oct 28, 2020
Deals

Out of the Arena: With $56M round, spinout Longboard to house trio of neuroscience programs

...Pharmaceuticals Inc. (NASDAQ:ARNA) took a major step in January, when the parent company formed its Arena Neuroscience Inc....
BioCentury | Feb 29, 2020
Management Tracks

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

...said EVP and CFO Kevin Lind will transition to president and CEO of its subsidiary Arena Neuroscience Inc....
Items per page:
1 - 2 of 2